A Biomarker-driven Therapeutic Strategy for Esophageal Cancer Chemoradiotherapy in Patients With Resectable Adenocarcinoma of the ESophagus and Esophagogastric Junction

NCT04269083 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

128

Enrollment

OTHER

Sponsor class

Conditions

Esophageal Cancer

Interventions

OTHER: BIRC3

Sponsor

Azienda Ospedaliera Universitaria Integrata Verona